 | Up a level |
Nadarajan, V.S. and Ang, C.H. and Syed-Sultan, M.K. and Bee, P.C. (2012) Imatinib resistance and blast transformation of chronic myeloid leukemia associated with a novel tri-nucleotide insertion mutation of BCR-ABL kinase domain at position K294. Annals of Hematology, 91 (1). pp. 125-127. ISSN 0939-5555, DOI https://doi.org/10.1007/s00277-011-1215-2.
Nadarajan, V.S. and Phan, C.L. and Ang, C.H. and Liang, K.L. and Gan, G.G. and Bee, P.C. and Zakaria, Z. (2011) Identification of copy number alterations by array comparative genomic hybridization in patients with late chronic or accelerated phase chronic myeloid leukemia treated with imatinib mesylate. International Journal of Hematology, 93 (4). pp. 465-473. ISSN 0925-5710, DOI https://doi.org/10.1007/s12185-011-0796-9.
Sim, E.U.H. and Ang, C.H. and Ng, C.C. and Lee, C.W. and Narayanan, K. (2010) Differential expression of a subset of ribosomal protein genes in cell lines derived from human nasopharyngeal epithelium. Journal of Human Genetics, 55 (2). pp. 118-120.
Ang, C.H. and Phan, C.L. and Gan, G.G. and Sultan, M.S. and Nadarajan, V. (2010) High resolution melt curve analysis as a tool for screening tyrosine kinase domain mutations in patients with chronic myeloid leukemia on tyrosine kinase inhibitors. Haematologica-The Hematology Journal, 95 (2). p. 335.
Phan, C.L. and Ang, C.H. and Liang, K.L. and Gan, G.G. and Zakaria, Z. and Nadarajan, V. (2010) Identification of unbalanced genomic aberrations by array cgh in chronic myeloid leukemia patients with suboptimal response to imatinib treatment. Haematologica-The Hematology Journal, 95 (2). p. 340.
Ang, C.H. and Gan, G.G. and Nadarajan, V. (2010) Suppressor of cytokine signaling 3 is down-regulated by BCR-ABL and results in loss of JAK2 V617F in a patient with concurrent BCR-ABL translocation and JAK2 V617F mutation. Haematologica-The Hematology Journal, 95 (2). pp. 402-403.
Ang, C.H. and Phan, C.L. and Gan, G.G. and Sultan, M.S. and Nadarajan, V. (2010) The roles of ceramide generating and ceramide clearence genes in apoptosis in chronic myeloid leukemia cells exposed to dasatinib. Haematologica-The Hematology Journal, 95 (2). pp. 335-336.
